An immunomodulatory activity of micafungin in preclinical aspergillosis | Zendy

Silvia Moretti | Zendy; Silvia Bozza | Zendy; Cristina Massi-Benedetti | Zendy; Lucia Prezioso | Zendy; Elena Rossetti | Zendy; Luigina Romani | Zendy; Franco Aversa | Zendy; Lucia Pitzurra | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

An immunomodulatory activity of micafungin in preclinical aspergillosis

Author(s) -

Silvia Moretti,

Silvia Bozza,

Cristina Massi-Benedetti,

Lucia Prezioso,

Elena Rossetti,

Luigina Romani,

Franco Aversa,

Lucia Pitzurra

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt457

Subject(s) - micafungin , aspergillosis , echinocandins , microbiology and biotechnology , medicine , echinocandin , pharmacology , antifungal , immunology , chemistry , biology , amphotericin b , caspofungin , fluconazole

Micafungin inhibits 1,3-β-D-glucan synthase and interferes with fungal cell wall synthesis. Clinically, micafungin has been shown to be efficacious for the treatment of invasive fungal infections. However, little is known about the immunomodulatory activity of micafungin in these infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research